{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T14:51:28Z","timestamp":1774882288090,"version":"3.50.1"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.ejmech.2021.114091","type":"journal-article","created":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T10:45:31Z","timestamp":1641033931000},"page":"114091","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Dual Sigma-1 receptor antagonists and hydrogen sulfide-releasing compounds for pain treatment: Design, synthesis, and pharmacological evaluation"],"prefix":"10.1016","volume":"230","author":[{"given":"Maria","family":"Dichiara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonia","family":"Artacho-Cord\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rita","family":"Turnaturi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5713-4136","authenticated-orcid":false,"given":"Miriam","family":"Santos-Caballero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael","family":"Gonz\u00e1lez-Cano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorella","family":"Pasquinucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6155-6702","authenticated-orcid":false,"given":"Carla","family":"Barbaraci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabel","family":"Rodr\u00edguez-G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"G\u00f3mez-Guzm\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8728-8857","authenticated-orcid":false,"given":"Agostino","family":"Marrazzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1308-6264","authenticated-orcid":false,"given":"Enrique J.","family":"Cobos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4750-3479","authenticated-orcid":false,"given":"Emanuele","family":"Amata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2021.114091_bib1","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1007\/s00228-015-1871-6","article-title":"Healthcare costs associated with elderly chronic pain patients in primary care","volume":"71","author":"Lazkani","year":"2015","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejmech.2021.114091_bib2","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.neubiorev.2020.03.004","article-title":"The search for translational pain outcomes to refine analgesic development: where did we come from and where are we going?","volume":"113","author":"Gonz\u00e1lez-Cano","year":"2020","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.ejmech.2021.114091_bib3","doi-asserted-by":"crossref","first-page":"15187","DOI":"10.1021\/acs.jmedchem.0c01192","article-title":"Small molecules selectively targeting sigma-1 receptor for the treatment of neurological diseases","volume":"63","author":"Ye","year":"2020","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.114091_bib4","doi-asserted-by":"crossref","first-page":"231","DOI":"10.4155\/fmc-2017-0164","article-title":"Novel Sigma-1 receptor antagonists: from opioids to small molecules: what is new?","volume":"10","author":"Arena","year":"2018","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ejmech.2021.114091_bib5","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/164_2017_9","article-title":"Sigma-1 receptor and pain","volume":"244","author":"Merlos","year":"2017","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.ejmech.2021.114091_bib6","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.tips.2003.10.007","article-title":"Hydrogen sulfide: from the smell of the past to the mediator of the future?","volume":"24","author":"Moore","year":"2003","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejmech.2021.114091_bib7","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jare.2020.05.007","article-title":"Hydrogen sulfide and vascular regulation - an update","volume":"27","author":"Lv","year":"2021","journal-title":"J.\u00a0Adv. Res."},{"key":"10.1016\/j.ejmech.2021.114091_bib8","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/sj.bjp.0706186","article-title":"Hydrogen sulphide is a mediator of carrageenan-induced hindpaw oedema in the rat","volume":"145","author":"Bhatia","year":"2005","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2021.114091_bib9","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.pain.2007.01.026","article-title":"Hydrogen sulfide as a novel nociceptive messenger","volume":"132","author":"Kawabata","year":"2007","journal-title":"Pain"},{"key":"10.1016\/j.ejmech.2021.114091_bib10","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ejphar.2008.05.048","article-title":"Dual role of hydrogen sulfide in mechanical inflammatory hypernociception","volume":"590","author":"Cunha","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2021.114091_bib11","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.neuropharm.2017.04.029","article-title":"Effects of natural and synthetic isothiocyanate-based H(2)S-releasers against chemotherapy-induced neuropathic pain: role of Kv7 potassium channels","volume":"121","author":"Di Cesare Mannelli","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejmech.2021.114091_bib12","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1744-8069-6-36","article-title":"Hydrogen sulphide induces micro opioid receptor-dependent analgesia in a rodent model of visceral pain","volume":"6","author":"Distrutti","year":"2010","journal-title":"Mol. Pain"},{"key":"10.1016\/j.ejmech.2021.114091_bib13","doi-asserted-by":"crossref","first-page":"514898","DOI":"10.1155\/2014\/514898","article-title":"Sodium hydrosulfide relieves neuropathic pain in chronic constriction injured rats","author":"Lin","year":"2014","journal-title":"Evid. base Compl. Alternative Med.: eCAM, 2014"},{"key":"10.1016\/j.ejmech.2021.114091_bib14","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1111\/bph.14641","article-title":"A\u00a0proof-of-concept, Phase 2 clinical trial of the gastrointestinal safety of a hydrogen sulfide-releasing anti-inflammatory drug","volume":"177","author":"Wallace","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2021.114091_bib15","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1111\/j.1476-5381.2012.01942.x","article-title":"Pharmacological properties of S1RA, a new sigma-1 receptor antagonist that inhibits neuropathic pain and activity-induced spinal sensitization","volume":"166","author":"Romero","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2021.114091_bib16","first-page":"157","article-title":"Combination drug therapy for chronic pain: a call for more clinical studies","volume":"12","author":"Mao","year":"2011","journal-title":"J.\u00a0Pain"},{"key":"10.1016\/j.ejmech.2021.114091_bib17","first-page":"1084","article-title":"Combination pharmacotherapy for management of chronic pain: from bench to bedside, the Lancet","volume":"12","author":"Gilron","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.ejmech.2021.114091_bib18","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.2174\/1381612822666160224142812","article-title":"Polypharmacology in drug discovery: a review from systems pharmacology perspective","volume":"22","author":"Zhang","year":"2016","journal-title":"Curr. Pharmaceut. Des."},{"key":"10.1016\/j.ejmech.2021.114091_bib19","doi-asserted-by":"crossref","first-page":"15508","DOI":"10.1021\/acs.jmedchem.0c01127","article-title":"Discovery of EST73502, a dual \u03bc-opioid receptor agonist and \u03c3(1) receptor antagonist clinical candidate for the treatment of pain","volume":"63","author":"Garc\u00eda","year":"2020","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.114091_bib20","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1021\/acs.jmedchem.9b01256","article-title":"4-Aryl-1-oxa-4,9-diazaspiro[5.5]undecane derivatives as dual \u03bc-opioid receptor agonists and \u03c3(1) receptor antagonists for the treatment of pain","volume":"63","author":"Garc\u00eda","year":"2020","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.114091_bib21","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.bcp.2017.11.014","article-title":"A\u00a0review of hydrogen sulfide (H(2)S) donors: chemistry and potential therapeutic applications","volume":"149","author":"Powell","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2021.114091_bib22","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1021\/cb400090d","article-title":"Controllable hydrogen sulfide donors and their activity against myocardial ischemia-reperfusion injury","volume":"8","author":"Zhao","year":"2013","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ejmech.2021.114091_bib23","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s00213-005-0127-z","article-title":"Antinociceptive effects of haloperidol and its metabolites in the formalin test in mice","volume":"182","author":"Cend\u00e1n","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejmech.2021.114091_bib24","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00213-009-1513-8","article-title":"Antagonism by haloperidol and its metabolites of mechanical hypersensitivity induced by intraplantar capsaicin in mice: role of sigma-1 receptors","volume":"205","author":"Entrena","year":"2009","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejmech.2021.114091_bib25","doi-asserted-by":"crossref","first-page":"9960","DOI":"10.1021\/acs.jmedchem.6b01039","article-title":"Antiangiogenic effect of (\u00b1)-Haloperidol metabolite II valproate ester [(\u00b1)-MRJF22] in human microvascular retinal endothelial cells","volume":"59","author":"Olivieri","year":"2016","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.114091_bib26","doi-asserted-by":"crossref","first-page":"117348","DOI":"10.1016\/j.lfs.2020.117348","article-title":"Design and synthesis of N-(benzylpiperidinyl)-4-fluorobenzamide: a haloperidol analog that reduces neuropathic nociception via \u03c3(1) receptor antagonism","volume":"245","author":"D\u00e9ciga-Campos","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.ejmech.2021.114091_bib27","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1021\/acsmedchemlett.9b00661","article-title":"Sigma receptor ligands carrying a nitric oxide donor nitrate moiety: synthesis, in silico, and biological evaluation","volume":"11","author":"Amata","year":"2020","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2021.114091_bib28","doi-asserted-by":"crossref","first-page":"9531","DOI":"10.1021\/acs.jmedchem.7b00791","article-title":"Novel sigma receptor ligand-nitric oxide photodonors: molecular hybrids for double-targeted antiproliferative effect","volume":"60","author":"Amata","year":"2017","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.114091_bib29","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1021\/acsmedchemlett.9b00549","article-title":"Novel N-substituted benzomorphan-based compounds: from MOR-agonist\/DOR-antagonist to biased\/unbiased MOR agonists","volume":"11","author":"Pasquinucci","year":"2020","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2021.114091_bib30","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1021\/acschemneuro.9b00688","article-title":"Exploiting the power of stereochemistry in drug action: 3-[(2S,6S,11S)-8-Hydroxy-6,11-dimethyl-1,4,5,6-tetrahydro-2,6-methano-3-benzazocin-3(2H)-yl]-N-phenylpropanamide as potent sigma-1 receptor antagonist","volume":"11","author":"Turnaturi","year":"2020","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejmech.2021.114091_bib31","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1021\/acs.jmedchem.7b01584","article-title":"(+)-Methyl (1R,2S)-2-{[4-(4-Chlorophenyl)-4-hydroxypiperidin-1-yl]methyl}-1-phenylcyclopropanecarboxylate [(+)-MR200] derivatives as potent and selective sigma receptor ligands: stereochemistry and pharmacological properties","volume":"61","author":"Amata","year":"2018","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.114091_bib32","first-page":"23","article-title":"Synthesis and structure-activity relationships of LP1 derivatives: N-methyl-N-phenylethylamino analogues as novel MOR agonists","author":"Turnaturi","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2021.114091_bib33","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.pain.2010.09.030","article-title":"Central sensitization: implications for the diagnosis and treatment of pain","volume":"152","author":"Woolf","year":"2011","journal-title":"Pain"},{"key":"10.1016\/j.ejmech.2021.114091_bib34","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0304-3959(95)00029-R","article-title":"Effects of intravenous ketamine, alfentanil, or placebo on pain, pinprick hyperalgesia, and allodynia produced by intradermal capsaicin in human subjects","volume":"63","author":"Park","year":"1995","journal-title":"Pain"},{"key":"10.1016\/j.ejmech.2021.114091_bib35","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.pain.2009.03.011","article-title":"Sigma-1 receptors are essential for capsaicin-induced mechanical hypersensitivity: studies with selective sigma-1 ligands and sigma-1 knockout mice","volume":"143","author":"Entrena","year":"2009","journal-title":"Pain"},{"key":"10.1016\/j.ejmech.2021.114091_bib36","doi-asserted-by":"crossref","first-page":"5157","DOI":"10.1021\/acs.jmedchem.1c00244","article-title":"Tricyclic triazoles as \u03c3(1) receptor antagonists for treating pain","volume":"64","author":"D\u00edaz","year":"2021","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.114091_bib37","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.chembiol.2021.01.009","article-title":"Discovery of a \u03c3(1) receptor antagonist by combination of unbiased cell painting and thermal proteome profiling","volume":"28","author":"Wilke","year":"2021","journal-title":"Cell chem. biol."},{"key":"10.1016\/j.ejmech.2021.114091_bib38","doi-asserted-by":"crossref","first-page":"14979","DOI":"10.1021\/acs.jmedchem.0c01575","article-title":"EST64454: a highly soluble \u03c3(1) receptor antagonist clinical candidate for pain management","volume":"63","author":"D\u00edaz","year":"2020","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.114091_bib39","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S0022-3565(24)29450-7","article-title":"Drug synergism: its detection and applications","volume":"298","author":"Tallarida","year":"2001","journal-title":"J.\u00a0Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejmech.2021.114091_bib40","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0304-3959(02)00041-6","article-title":"The interaction index: a measure of drug synergism","volume":"98","author":"Tallarida","year":"2002","journal-title":"Pain"},{"key":"10.1016\/j.ejmech.2021.114091_bib41","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1124\/jpet.113.208272","article-title":"Modulation of peripheral \u03bc-opioid analgesia by \u03c31 receptors","volume":"348","author":"S\u00e1nchez-Fern\u00e1ndez","year":"2014","journal-title":"J.\u00a0Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejmech.2021.114091_bib42","doi-asserted-by":"crossref","first-page":"613","DOI":"10.3389\/fphar.2019.00613","article-title":"Sigma-1 receptor inhibition reduces neuropathic pain induced by partial sciatic nerve transection in mice by opioid-dependent and -independent mechanisms","volume":"10","author":"Bravo-Caparr\u00f3s","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2021.114091_bib43","doi-asserted-by":"crossref","first-page":"105339","DOI":"10.1016\/j.phrs.2020.105339","article-title":"Sigma-1 receptor: a drug target for the modulation of neuroimmune and neuroglial interactions during chronic pain","volume":"163","author":"Ruiz-Cantero","year":"2021","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejmech.2021.114091_bib44","series-title":"Handbook of Pharmacogenomics and Stratified Medicine","first-page":"405","article-title":"Chapter 20 - adverse drug reactions","author":"Walker","year":"2014"},{"key":"10.1016\/j.ejmech.2021.114091_bib45","doi-asserted-by":"crossref","DOI":"10.1002\/0471141755.ph1001s32","article-title":"Overview of safety pharmacology","author":"Porsolt","year":"2006","journal-title":"Curr. protoc. pharmacol."},{"key":"10.1016\/j.ejmech.2021.114091_bib46","first-page":"1107","article-title":"Role of sigma-1 receptors in paclitaxel-induced neuropathic pain in mice","volume":"13","author":"Nieto","year":"2012","journal-title":"J.\u00a0Pain"},{"key":"10.1016\/j.ejmech.2021.114091_bib47","doi-asserted-by":"crossref","first-page":"112290","DOI":"10.1016\/j.ejmech.2020.112290","article-title":"hERG toxicity assessment: useful guidelines for drug design","volume":"195","author":"Garrido","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.114091_bib48","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19051438","article-title":"Hydrogen sulfide in hypertension and kidney disease of developmental origins","volume":"19","author":"Hsu","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2021.114091_bib49","doi-asserted-by":"crossref","first-page":"H732","DOI":"10.1152\/ajpheart.00729.2016","article-title":"Analysis of decreases in systemic arterial pressure and heart rate in response to the hydrogen sulfide donor sodium sulfide","volume":"313","author":"Swan","year":"2017","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.ejmech.2021.114091_bib50","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1021\/acschemneuro.9b00541","article-title":"Tuning properties for blood-brain barrier permeation: a statistics-based analysis","volume":"11","author":"Dichiara","year":"2020","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejmech.2021.114091_bib51","doi-asserted-by":"crossref","first-page":"10327","DOI":"10.1002\/anie.201104305","article-title":"Capture and visualization of hydrogen sulfide by a fluorescent probe","volume":"50","author":"Liu","year":"2011","journal-title":"Angew. Chem."},{"key":"10.1016\/j.ejmech.2021.114091_bib52","doi-asserted-by":"crossref","first-page":"344","DOI":"10.2174\/157015908787386113","article-title":"Pharmacology and therapeutic potential of sigma(1) receptor ligands","volume":"6","author":"Cobos","year":"2008","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.ejmech.2021.114091_bib53","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1161\/HYPERTENSIONAHA.114.03587","article-title":"Chronic hydroxychloroquine improves endothelial dysfunction and protects kidney in a mouse model of systemic lupus erythematosus","volume":"64","author":"G\u00f3mez-Guzm\u00e1n","year":"2014","journal-title":"Hypertension (Dallas, Tex: 1979"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523421009405?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523421009405?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:34:46Z","timestamp":1759329286000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523421009405"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":53,"alternative-id":["S0223523421009405"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2021.114091","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dual Sigma-1 receptor antagonists and hydrogen sulfide-releasing compounds for pain treatment: Design, synthesis, and pharmacological evaluation","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2021.114091","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114091"}}